Mr. Gregory D. Cash Edit

Education

View...

Biography

Greg Cash is an experienced executive and seasoned veteran of the healthcare industry. He joined HeartSine in December 2006 as President and Chief Executive Officer.

Prior to joining HeartSine, he was with the Sorin Group as President, Vascular Therapy and New Businesses at their corporate headquarters in Milan, Italy and later in their US headquarters. Previously, Mr. Cash was President...

 View all 188 references Web References

1. 1. HeartSine

   www.heartsine.com/abouths-mana - [Cached]

   Published on: 3/14/2008   Last Visited: 3/14/2008

   Gregory Cash, President & Chief Executive Officer Greg Cash is an experienced executive and a seasoned veteran of the healthcare industry. He joined HeartSine® in December 2006 as President & CEO, and is also a member of the HeartSine Board of Directors (below).
   
   Prior to joining HeartSine®, he was with the Sorin Group as President, Vascular Therapy and New Businesses at their corporate headquarters in Milan, Italy and later in their US headquarters. Previously, Mr. Cash was President and Chief Executive Officer as well as a director of Vasomedical, Inc. a NASDAQ traded manufacturer and marketer of devices to treat heart disease, Corporate Vice President, Datascope Corporation, and President of its subsidiary, InterVascular, Inc., President and Chief Operating Officer of Eminent Technology Partners and Chief Executive Office of its subsidiary, Eminent Research Systems, a clinical research organization, Vice President and General Manager, Vascular Therapies, for U.S. Surgical Corporation and spent five years with Boston Scientific Corporation, ultimately as Vice President, Cardiology Sales and Marketing, Europe. He began his career at Medtronic, Inc., where he served 14 years in increasingly senior sales and marketing positions.
   
   Mr. Cash has lived and worked in the United Kingdom, Hong Kong, France and Italy and speaks French, German and Italian. He holds a B.A. in International Marketing and Business Administration from the College of St. Thomas in St. Paul, Minnesota.
   ...
   Gregory Cash, President & CEO

2. 2. www.corporate-ir.net

   www.corporate-ir.net/ireye/ir_ - [Cached]

   Published on: 10/15/2003   Last Visited: 5/30/2008

   Gregory D. Cash, Vasomedical's President and Chief Executive
   ...
   to achieve these goals over the long term," concluded Cash.
   
   As previously announced, the Company will host a conference call to discuss first quarter 2003 results.Mr. Gregory D. Cash, President

3. 3. Vasomedical, Inc. - Investor Relations - Press Releases

   phx.corporate-ir.net/phoenix.z - [Cached]

   Published on: 5/29/2003   Last Visited: 5/12/2008

   Gregory D. Cash Appointed Chief Executive Officer of VasomedicalVasomedical, Inc. - Investor Relations - Press Releases
   ...
   Gregory D. Cash Appointed Chief Executive Officer of Vasomedical
   
   WESTBURY, N.Y., May 29, 2003 (BUSINESS WIRE) -- Vasomedical (Nasdaq:VASO) announced today that Gregory D. Cash has been appointed to the position of Chief Executive Officer, and has been elected to the company's Board of Directors, effective June 30, 2003, and will continue as President of Vasomedical as well.
   
   Cash will replace Photios T. (Fred) Paulson, who will remain a member of Vasomedical's Board of Directors and will act as an advisor to the Company.
   ...
   Fred, who worked very closely with Mr. Cash during this time, along with the rest of the Board, fully supports his appointment as chief executive officer; we are confident that Greg is the right person to lead Vasomedical forward."
   
   Since joining Vasomedical as President and Chief Operating Officer in October 2002, Cash has implemented a number of programs designed to drive the future of EECP therapy.He has helped to streamline the Company's clinical activities to focus on obtaining reimbursement for congestive heart failure (CHF) and to support the additional existing cardiovascular indications for which EECP is approved.In addition, he has refocused Vasomedical's sales and marketing efforts to expand awareness of EECP aimed at growing the core angina business, while laying the foundation for acceptance of the congestive heart failure indication in the medical community and Medicare reimbursement.
   
   A seasoned healthcare veteran, with over 25 years experience in the medical devices industry, Cash joined Vasomedical from Datascope Corporation, where he served as Corporate Vice President as well as President of Intervascular, Inc., a wholly owned subsidiary of Datascope.Cash was previously President and Chief Executive Officer of Eminent Research Systems, Inc., a clinical trials management and regulatory consulting company, prior to which he was Vice President and General Manager, Vascular Therapies, for U.S. Surgical Corporation, where he had global responsibility for a 350-person business unit consisting of sales, marketing, manufacturing operations and R&D departments.He previously spent five years with Boston Scientific Corporation, ultimately as Vice President, Cardiology Sales and Marketing, Europe, prior to which he served 14 years at Medtronic, Inc. in increasingly senior sales and marketing positions.Cash holds a BA in international marketing and business administration from the College of St. Thomas in St. Paul, Minnesota.